Novartis becomes new partner of CQDM's Explore programme
Novartis has invested in the Explore programme to help fund cutting-edge pharmaceutical research in Quebec.
Novartis Pharmaceuticals Canada has agreed to partner in the Explore programme of the CQDM.
CQDM provides a meeting ground for stakeholders in biopharmaceutical research in Canada, funding projects carried out in partnership between the academic and private sectors to accelerate the drug discovery process and develop safer, more effective drugs.
Its Explore programme aims to fund unconventional and innovative research projects that could lead to significant improvements to the drug discovery or development process.
Novartis is now investing $300,000 in the project, having already invested approximately 30 per cent of its total sales in the province over the past five years.
Dr Riad Sherif, president of Novartis Pharmaceuticals Canada, said the company was "very pleased" to be joining the CQDM and its partners "in this very important programme to encourage cutting-edge pharmaceutical research in Quebec".
He revealed: "The Explore programme is fully compatible with the Novartis objectives to discover, develop and successfully market innovative products to prevent and cure disease, to ease suffering and to enhance quality of life."
Diane Gosselin, president and chief executive officer of CQDM, welcomed Novartis as a partner and claimed that the programme had become "an important means for Quebec researchers with new ideas to secure funding to pursue their innovative approaches".
Related News
-
News BioNTech to begin mRNA vaccine manufacturing in Rwanda by 2025
German biotechnology company BioNTech has stated their intentions to begin production at their mRNA vaccine factory in Rwanda by 2025, which will mark the first foreign mRNA vaccine manufacturing site on the continent of Africa. -
News Identifying Alzheimer’s Disease biomarker proteins with whole blood tests
A University of Manchester spin-out pharmaceutical company, PharmaKure, has reported successful study results for the quantification of Alzheimer’s Disease biomarker proteins with a whole blood test. -
News Bill & Melinda Gates Foundation to boost mRNA vaccine initiatives in Africa with USD $40m
To address vaccine inequality and accessibility issues, the Bill & Melinda Gates Foundation aims to deliver USD $40m to various biotech companies and vaccine manufacturers in support of mRNA vaccine development. -
News CPHI Podcast Series: Exploring neurological frontiers in Alzheimer's and beyond
The next episode of the CPHI Podcast Series delves into the science and background behind some recent developments in the field of Alzheimer's disease and neurological disorders. -
News Is patient centricity the future of pharmaceutical manufacturing?
In this interview with Sandra Sánchez y Oldenhage, President of PharmAdvice, she speaks to the importance of considering patients in the manufacturing stages of the pharmaceutical supply chain, and how it can redefine healthcare. -
News CPHI Podcast Series: How to leverage AI for Drug Discovery
Artificial intelligence is the topic of debate in the latest episode from the CPHI Podcast Series, where Digital Editor Lucy Chard speaks with Bill Whitford of DPS Group about the integration of AI in healthcare. -
News Pfizer forges ahead with blood cancer therapy after approval from FDA
Pfizer gains accelerated approval from the US FDA for their new bispecific antibody therapy for multiple myeloma, set to address an unmet need for patients. -
News Alzheimer's drug donanemab deemed effective in landmark clinical trial
Results from the TRAILBLAZER-ALZ 2 Randomised Clinical Trial into the use of donanemab to treat early symptoms of Alzheimer’s disease have been analysed.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance